Home › NDC Lookup › RxCUI directory › RxCUI 1718589

Trabectedin 1 MG Injection — RxCUI 1718589

RxNorm drug concept · Semantic clinical drug
RxCUI 1718589 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1718589
Official nameTrabectedin 1 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)614 prescriptions · 10 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Trabectedin Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Trabectedin injection — sold as Yondelis and Evdi — is used to treat two specific types of soft tissue cancer: liposarcoma (cancer of fat tissue) and leiomyosarcoma (cancer of smoo...
  • What exactly is trabectedin used to treat?
  • Trabectedin is given as an IV infusion that runs continuously over 24 hours — so it's a full-day treatment in a clinical setting. You'll come in once every 3 weeks, which is one tr...
  • How is this drug given, and how often will I need to come in?
📖 Read our full Trabectedin Injection guide →

🕸️ Concept Web — How Trabectedin 1 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Trabectedin 1 MG Injection RxCUI 1718589

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Trabectedin 1716278
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Yondelis 1718590
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Trabectedin Injection 1718588
    • Trabectedin Injectable Product 1718587
    • Trabectedin Injection [Yondelis] 1718592
    • Yondelis Injectable Product 1718593
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Trabectedin 1 MG SCDC · 1718586
  • Trabectedin Injection SCDF · 1718588
  • Trabectedin Injectable Product SCDG · 1718587

Brand-Name Concepts

  • Trabectedin 1 MG Injection [Yondelis] SBD · 1718594
  • Trabectedin 1 MG [Yondelis] SBDC · 1718591
  • Trabectedin Injection [Yondelis] SBDF · 1718592
  • Yondelis Injectable Product SBDG · 1718593
  • Yondelis BN · 1718590

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 1718589 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
59676-0610-01 20 mL in 1 VIAL, SINGLE-USE (59676-610-01) YONDELIS Janssen Products, LP 2015-10-23
Observed labelers: Janssen Products, LP (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J9352 Injection trabectedin 0.1mg 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.